Resting energy expenditure in the parenterally fed pediatric population with Crohn's disease

被引:15
|
作者
Cormier, K
Mager, D
Bannister, L
Fortin, M
Richards, H
Jackson, C
Pencharz, P
机构
[1] Hosp Sick Children, Div Gastroenterol Nutr, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Dept Clin Dietet, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada
[4] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
关键词
D O I
10.1177/0148607105029002102
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Malnutrition is a common sequela of Crohn's disease (CD) and may result in reduced skeletal muscle function and growth retardation. Energy requirements of parenterally fed hospitalized pediatric patients with active CD were measured using indirect calorimetry, to assess whether Food Agriculture Organization (FAO)/World Health Organization (WHO)/United Nations University (UNU) equations provide appropriate estimations of energy requirements in this patient population. Methods: Twenty hospitalized patients with active CD fed exclusively via parenteral nutrition (PN) were investigated. A chart review and patient interviews were conducted to assess disease duration, location, laboratory parameters, and symptomology associated with CD. Disease severity was quantified using the Pediatric Crohn's Disease Activity Index. Each subject underwent indirect calorimetry, bioelectrical impedance analysis, and anthropometric assessment once the ordered PN met estimated macronutrient requirements of each patient (predicted resting energy expenditure X 1.3). Predicted resting energy expenditure (REE) was determined using the FAO/WHO/UNU equations. Results: REE showed a strong correlation with predicted REE (r(2) = .73, p < .01). Conclusions: Measured REE did not significantly differ from predicted resting energy requirements. This indicates that REE for the parenterally fed pediatric patients with CD can. be accurately predicted using the FAO/WHO/UNU equations.
引用
收藏
页码:102 / 107
页数:6
相关论文
共 50 条
  • [41] RESTING ENERGY-EXPENDITURE IN INTERSTITIAL LUNG-DISEASE
    FITTING, JW
    FRASCAROLO, P
    JEQUIER, E
    LEUENBERGER, P
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (03): : 631 - 635
  • [42] Changes in resting energy expenditure in children with congenital heart disease
    A Nydegger
    A Walsh
    D J Penny
    R Henning
    J E Bines
    European Journal of Clinical Nutrition, 2009, 63 : 392 - 397
  • [43] Prediction equation of resting energy expenditure in an adult Spanish population of obese adult population
    de Luis, D. A.
    Aller, R.
    Izaola, O.
    Romero, E.
    ANNALS OF NUTRITION AND METABOLISM, 2006, 50 (03) : 193 - 196
  • [44] The Association of Leptin Gene Polymorphisms with Crohn's Disease in a Chinese Pediatric Population
    Sun, Anna
    Li, Wei
    Shi, Jianrong
    Wang, Hao
    Shu, Xiaoli
    Shang, Shiqiang
    IRANIAN JOURNAL OF PEDIATRICS, 2023, 33 (03)
  • [45] Pediatric Crohn's disease patients
    Pittschieler, K.
    MONATSSCHRIFT KINDERHEILKUNDE, 2006, 154 (11) : 1124 - 1124
  • [46] INFLIXIMAB FOR PEDIATRIC CROHN'S DISEASE
    Hoffman, I.
    Vermeire, S.
    Van Assche, G.
    Rutgeerts, P.
    DRUGS OF TODAY, 2008, 44 (08) : 615 - 628
  • [47] USTEKINUMAB IN PEDIATRIC CROHN'S DISEASE
    Dilillo, A.
    Civitelli, F.
    Oliva, S.
    Votto, M.
    Aloi, M.
    Isoldi, S.
    Mallardo, S.
    Rossi, P.
    Viola, F.
    Cucchiara, S.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E262 - E263
  • [48] Pediatric Management of Crohn?s Disease
    Mitchel, Elana B.
    Rosh, Joel R.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (02) : 401 - 424
  • [49] Adalimumab in pediatric Crohn's disease
    Patel, Ashish S.
    Suarez, Lisbet D.
    Rosh, Joel R.
    IMMUNOTHERAPY, 2016, 8 (02) : 127 - 133
  • [50] Increased resting lipid oxidation in Crohn's disease
    Mingrone, G
    Greco, AV
    Benedetti, G
    Capristo, E
    Semeraro, R
    Zoli, G
    Gasbarrini, G
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (01) : 72 - 76